Which antibiotic is associated with an increased risk of Achilles tendon rupture?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fluoroquinolones Cause Achilles Tendon Rupture

Fluoroquinolone antibiotics, particularly ciprofloxacin and levofloxacin, are the antibiotics most strongly associated with Achilles tendon rupture, carrying a black box FDA warning for this serious complication. 1

The Fluoroquinolone Class

Fluoroquinolones as a class increase the risk of Achilles tendon rupture with an odds ratio of 4.1 compared to non-users. 2, 3 The FDA issued a black box warning in 2008 for all fluoroquinolones citing increased risk of tendinitis and tendon rupture. 4

Specific fluoroquinolones implicated include:

  • Ciprofloxacin - most commonly prescribed and most frequently reported in case series 1, 5, 6
  • Levofloxacin - shows 120% increased risk (HR 2.20) for Achilles tendon rupture within 30 days of use 7, 8
  • Ofloxacin - demonstrated highest risk in multiple observational studies 9
  • Moxifloxacin - also carries the class warning 7

Risk Quantification

The absolute risk is approximately 12 additional cases of Achilles tendon rupture per 100,000 persons within 90 days of fluoroquinolone treatment. 2, 3 The Achilles tendon is affected in 90% of fluoroquinolone-associated tendon ruptures, with bilateral involvement occurring in more than half of cases. 3

High-Risk Populations Requiring Extreme Caution

Age over 60 years: 4-fold increased risk compared to general population, with 1 rupture expected per 1,638 treated patients. 2, 10

Concomitant corticosteroid use: Dramatically escalates risk to odds ratio of 43.2 for Achilles tendon rupture (1 rupture per 979 patients). 3, 10

Other high-risk factors include: 1

  • Kidney, heart, or lung transplant recipients
  • History of tendon disorders or rheumatoid arthritis
  • Renal failure
  • Active participation in sports or strenuous physical activity
  • Osteoarthritis 10

Timing of Rupture

Symptoms typically occur within 1 week of exposure (median 6 days), but can appear as early as 2 hours after the first dose or as late as 6 months after discontinuation. 2, 3 The highest risk period is within the first 30 days following exposure. 3

Mechanism of Toxicity

Fluoroquinolones chelate magnesium and other divalent cations, leading to reduced collagen type I, elastin, and fibronectin in tendons. 4 They also increase matrix metalloproteinase-3 (MMP-3) expression, induce apoptosis in tendon cells, and disrupt integrin-mediated cell signaling pathways critical for tendon integrity. 4

Critical Management Points

Discontinue the fluoroquinolone immediately at the first sign of tendon pain, swelling, or inflammation. 1 Patients should rest and avoid weight-bearing activities. 1

Consider magnesium supplementation during fluoroquinolone treatment if no contraindications exist, as recommended by the American College of Physical Medicine and Rehabilitation. 2

For high-risk individuals (over 60 years, corticosteroid users, athletes, transplant recipients), strongly consider alternative antibiotic classes when clinically appropriate. 2, 10

Common Pitfall

Do not assume tendon symptoms are simply musculoskeletal strain—fluoroquinolone-associated tendinopathy can progress rapidly to complete rupture if the antibiotic is continued. 1 MRI is useful to distinguish between tendinitis and partial rupture when clinical examination is equivocal. 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.